Black Rock Inc. Milestone Pharmaceuticals Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,971,344 shares of MIST stock, worth $9.89 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,971,344
Previous 4,971,344
-0.0%
Holding current value
$9.89 Million
Previous $8.9 Million
26.25%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MIST
# of Institutions
54Shares Held
18.6MCall Options Held
160KPut Options Held
34.8K-
Simplify Asset Management Inc. New York, NY2.83MShares$5.64 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.99 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.57 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.78 Million1.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$2.26 Million1.67% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $59.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...